A4GNT and gastric adenocarcinoma: Furthermore, a separate study utilized knockout mice deficient in alpha-1,4-N-acetylglucosaminyltransferase (A4gnt) to explore the development of gastric dysplasia and its progression to gastric adenocarcinoma (Desamero et al., 2018).